P2Y Purinergic Signaling in Prostate Cancer: Emerging Insights into Pathophysiology and Therapy

The authors review the pathological and immunomodulatory roles of P2Y purinergic nucleotide receptors in prostate cancer and their potential as therapeutic targets to address some of the clinical limitations in prostate cancer treatment.